|
ZNF627 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.280200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.109390E-01 |
| Normal-vs-Stage2 |
2.381000E-01 |
| Normal-vs-Stage3 |
4.257100E-03 |
| Normal-vs-Stage4 |
9.822500E-04 |
| Stage1-vs-Stage2 |
9.427400E-01 |
| Stage1-vs-Stage3 |
5.261900E-02 |
| Stage1-vs-Stage4 |
3.484900E-03 |
| Stage2-vs-Stage3 |
2.163400E-01 |
| Stage2-vs-Stage4 |
7.081700E-02 |
| Stage3-vs-Stage4 |
3.387000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.247540E-02 |
| Normal-vs-AfricanAmerican |
6.625400E-01 |
| Normal-vs-Asian |
7.856300E-02 |
| Caucasian-vs-AfricanAmerican |
2.219200E-01 |
| Caucasian-vs-Asian |
8.843800E-01 |
| AfricanAmerican-vs-Asian |
3.317600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.622100E-02 |
| Normal-vs-Female |
2.067800E-02 |
| Male-vs-Female |
7.086600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.475850E-01 |
| Normal-vs-Age(41-60Yrs) |
4.188200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.661800E-03 |
| Normal-vs-Age(81-100Yrs) |
4.162400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.014000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.949900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.994000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.791390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.927200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.174800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.582400E-03 |
| Classical-VS-Follicular |
5.674000E-01 |
| Classical-VS-Other |
9.704600E-01 |
| Classical-VS-Normal |
8.781500E-02 |
| Tall-VS-Follicular |
6.907600E-02 |
| Tall-VS-Other |
4.476000E-01 |
| Tall-VS-Normal |
1.758200E-03 |
| Follicular-VS-Other |
8.452400E-01 |
| Follicular-VS-Normal |
9.684400E-02 |
| Other-VS-Normal |
5.817000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.742400E-02 |
| Normal-vs-N1 |
6.015700E-04 |
| N0-vs-N1 |
7.916500E-03 |
|
|
